Metvian Trio 1mg/500mg/0.2mg Tablet SR
Marketer
Vivichem Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Metvian Trio 1mg/500mg/0.2mg Tablet SR
Triomix-D 1mg/500mg/0.2mg extended-release tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by managing blood glucose levels. Triomix-D should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical consultation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most frequent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary foods, juice) are vital. Alcohol consumption should be minimized due to its hypoglycemic effect. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Uses of Metvian Trio 1mg/500mg/0.2mg Tablet SR
Managing type 2 diabetes
Major Benefits of Metvian Trio 1mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Metvian Trio 1mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
Common Side effects of Metvian Trio 1mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Metvian Trio 1mg/500mg/0.2mg Tablet SR:
Consume Metvian Trio 1mg/500mg/0.2mg SR tablets precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication on an empty stomach.
How Metvian Trio 1mg/500mg/0.2mg Tablet SR works:
Metvian Trio extended-release tablets (1mg/500mg/0.2mg) contain a triple-drug formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Metvian Trio 1mg/500mg/0.2mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Metvian Trio 1mg/500mg/0.2mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Metvian Trio tablets (1mg/500mg/0.2mg) are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
Metvian Trio 1mg/500mg/0.2mg sustained-release tablets are likely unsafe for individuals with kidney impairment and should be omitted. A physician's consultation is advised. Moreover, Metvian Trio 1mg/500mg/0.2mg sustained-release tablets are unsuitable for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Metvian Trio 1mg/500mg/0.2mg Tablet SR cautiously, potentially requiring dosage modification. Consult a physician for guidance. Low initial doses are typically prescribed for those with mild to moderate hepatic dysfunction; the medication is contraindicated in patients with severe liver disease.
What if you forget to take Metvian Trio 1mg/500mg/0.2mg Tablet SR :
Should you forget a Metvian Trio 1mg/500mg/0.2mg Tablet SR dose, ingest it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Metvian Trio 1mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently